Charles River Laboratories International (CRL) reported a second quarter net loss attributable to common shareholders of $1.48 million compared to net income of $52.33 million, last year. Loss per share was $0.03 compared to profit of $1.06. Net income available to Charles River shareholders, excluding non-GAAP adjustments, was $146.24 million compared to $153.99 million, prior year. Excluding non-GAAP adjustments, profit per share declined to $3.02 from $3.12. Revenue was $1.00 billion, a decrease of 2.7% from $1.03 billion in the second quarter of 2025. On an organic basis, revenue increased 0.1%, for the quarter.
The company increased its 2026 revenue and non-GAAP earnings per share guidance. On a GAAP basis, the company reduced earnings per share guidance due primarily to thenet loss related to the divestitures. GAAP EPS is estimated at $3.05 - $3.35, revised from previous guidance of $5.35 - $5.85. Non-GAAP EPS is estimated at $11.15 - $11.45, updated from prior guidance of $10.80 - $11.30. Revenue growth, organic, is expected to be in a range of 0.0% - 1.0%, updated from prior guidance for a decline in a range of 1.5% - 0.5%.
In pre-market trading on NYSE, Charles River shares are up 8.8 percent to $254.73.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.